NCT00912301View on ClinicalTrials.gov

Cheno Effect on Transit in Health and IBS-C

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

November 30, 2009

Study Completion Date

December 31, 2009

Conditions
Constipation-predominant Irritable Bowel Syndrome
Interventions
DRUG

Sodium chenodeoxycholate (NaCDC)

500 or 1000 milligrams NaCDC per day each for a period of 4 days

OTHER

Placebo

Placebo capsules with identical appearance to the study drug were prepared by the Mayo Clinic research pharmacy.

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

National Center for Research Resources (NCRR)

NIH

lead

Mayo Clinic

OTHER